Skip to main content
Fig. 4 | BMC Infectious Diseases

Fig. 4

From: Lesion size as a prognostic factor in the antifungal treatment of pulmonary cryptococcosis: a retrospective study with chest CT pictorial review of 2-year follow up

Fig. 4

Follow-up of the area of pulmonary lesion. a Change in area of lesions at baseline and the last visit; b Change in area of residual lesions during follow-ups; c Percentage of the residual lesion in the total group; d Percentage of the residual lesion in the CR group (median: 1st month, 60.0%, n = 29; 3rd month, 30.4%, n = 31; 6th month, 8.9%, n = 27; 12th month, 1.3%, n = 22; 24th month, 0.0%, n = 11); e Percentage of the residual lesion in the non-CR group (median: 1st month, 56.3%, n = 26; 3rd month, 26.9%, n = 27; 6th month, 15.5%, n = 24; 12th month, 16.1%, n = 17; 24th month, 9.8%, n = 3)

Back to article page